News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,697 Results
Type
Article (26502)
Company Profile (133)
Press Release (276054)
Multimedia
Podcasts (64)
Webinars (6)
Section
Business (74395)
Career Advice (305)
Deals (12542)
Drug Delivery (56)
Drug Development (51574)
Employer Resources (28)
FDA (7194)
Job Trends (5879)
News (143178)
Policy (11988)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (2)
Academia (1595)
Academic (1)
Accelerated approval (38)
Adcomms (19)
Allergies (62)
Alliances (24230)
ALS (169)
Alzheimer's disease (1154)
Antibody-drug conjugate (ADC) (407)
Approvals (7478)
Artificial intelligence (296)
Autoimmune disease (247)
Automation (31)
Bankruptcy (67)
Best Places to Work (5227)
BIOSECURE Act (6)
Biosimilars (151)
Biotechnology (106)
Bladder cancer (147)
Brain cancer (55)
Breast cancer (505)
Cancer (4733)
Cardiovascular disease (180)
Career advice (261)
Career pathing (10)
CAR-T (351)
CDC (8)
Cell therapy (982)
Cervical cancer (33)
Clinical research (43856)
Collaboration (1319)
Company closure (4)
Compensation (402)
Complete response letters (51)
COVID-19 (1447)
CRISPR (93)
C-suite (573)
Cystic fibrosis (99)
Data (5237)
Decentralized trials (1)
Denatured (11)
Depression (97)
Dermatology (48)
Diabetes (275)
Diagnostics (2619)
Digital health (18)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (211)
Drug pricing (52)
Drug shortages (4)
Duchenne muscular dystrophy (158)
Earnings (27602)
Editorial (25)
Employer branding (4)
Employer resources (27)
Events (46032)
Executive appointments (500)
FDA (9198)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (21)
Funding (923)
Gene editing (196)
Generative AI (24)
Gene therapy (622)
GLP-1 (365)
Government (1590)
Grass and pollen (2)
Guidances (158)
Healthcare (7219)
HIV (50)
Huntington's disease (29)
IgA nephropathy (61)
Immunology and inflammation (193)
Immuno-oncology (85)
Indications (120)
Infectious disease (1606)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (138)
Interviews (62)
IPO (5804)
IRA (14)
Job creations (946)
Job search strategy (217)
JPM (42)
Kidney cancer (21)
Labor market (16)
Layoffs (230)
Leadership (8)
Legal (2001)
Liver cancer (77)
Longevity (22)
Lung cancer (758)
Lymphoma (426)
Machine learning (33)
Management (7)
Manufacturing (600)
MASH (67)
Medical device (2910)
Medtech (2952)
Mergers & acquisitions (7338)
Metabolic disorders (571)
mRNA (151)
Multiple sclerosis (151)
NASH (4)
Neurodegenerative disease (258)
Neuropsychiatric disorders (58)
Neuroscience (2251)
Neurotech (1)
NextGen: Class of 2026 (2169)
Non-profit (2056)
Now hiring (20)
Obesity (214)
Opinion (123)
Ovarian cancer (191)
Pain (88)
Pancreatic cancer (194)
Parkinson's disease (253)
Partnered (18)
Patents (289)
Patient recruitment (399)
Peanut (21)
People (22279)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase 1 (15516)
Phase 2 (19714)
Phase 3 (13604)
Pipeline (4903)
Policy (90)
Postmarket research (1130)
Preclinical (7142)
Press Release (58)
Prostate cancer (190)
Psychedelics (26)
Radiopharmaceuticals (172)
Rare diseases (685)
Real estate (2018)
Recruiting (13)
Regulatory (11357)
Reports (22)
Research institute (1645)
Resumes & cover letters (45)
Rett syndrome (25)
RNA editing (17)
RSV (39)
Schizophrenia (125)
Series A (147)
Series B (108)
Service/supplier (3)
Sickle cell disease (121)
Special edition (14)
Spinal muscular atrophy (140)
Sponsored (24)
Startups (1733)
State (1)
Stomach cancer (18)
Supply chain (41)
Tariffs (18)
The Weekly (51)
Vaccines (498)
Venture capital (60)
Weight loss (106)
Women's health (33)
Worklife (2)
Date
Today (116)
Last 7 days (468)
Last 30 days (1744)
Last 365 days (15733)
2026 (6026)
2025 (15831)
2024 (18313)
2023 (20549)
2022 (27177)
2021 (27837)
2020 (24378)
2019 (17718)
2018 (13355)
2017 (14407)
2016 (13504)
2015 (16004)
2014 (11310)
2013 (9414)
2012 (9579)
2011 (9598)
2010 (8518)
Location
Africa (260)
Alabama (27)
Alaska (3)
Arizona (80)
Arkansas (5)
Asia (32499)
Australia (4712)
California (6578)
Canada (1773)
China (1061)
Colorado (184)
Connecticut (233)
Delaware (220)
Europe (46209)
Florida (736)
Georgia (140)
Hawaii (2)
Idaho (22)
Illinois (432)
India (62)
Indiana (144)
Iowa (15)
Japan (443)
Kansas (33)
Kentucky (15)
Louisiana (8)
Maine (66)
Maryland (799)
Massachusetts (5262)
Michigan (80)
Minnesota (198)
Mississippi (1)
Missouri (36)
Montana (11)
Nebraska (9)
Nevada (54)
New Hampshire (14)
New Jersey (1857)
New Mexico (16)
New York (1979)
North Carolina (734)
North Dakota (10)
Northern California (3311)
Ohio (201)
Oklahoma (8)
Oregon (8)
Pennsylvania (1266)
Puerto Rico (7)
Rhode Island (25)
South America (342)
South Carolina (11)
Southern California (2614)
Tennessee (51)
Texas (1139)
United States (22859)
Utah (161)
Virginia (162)
Washington D.C. (25)
Washington State (632)
Wisconsin (55)
302,697 Results for "cell cure neurosciences ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
April 15, 2026
·
3 min read
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform
January 5, 2026
·
5 min read
Press Releases
Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
April 20, 2026
·
6 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Groundbreaking Danish research project launches to cure Parkinson’s disease
March 23, 2026
·
4 min read
Press Releases
CURE ALZHEIMER’S FUND PRESENTS THE 2026 JEFFREY L. MORBY PRIZE FOR EXCEPTIONAL RESEARCH
May 6, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Diabetes
Vertex’s Cell Therapy Could Be ‘Functional Cure’ for Diabetes, but Market Prospects Uncertain
While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target population and Vertex’s execution hang over the cell therapy’s commercial potential.
June 23, 2025
·
2 min read
·
Tristan Manalac
1 of 30,270
Next
